Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.47 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.47 |
| ▸ | GRM6 | O15303 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14409083 | 1.00 | GRM2 (0.47) | GRM2GRM3GRM6DPP4EPHX2 | |
| SCHEMBL23274871 | 0.85 | EPHX2 (0.44) | GRM2GRM3DPP4EPHX2CTSL | |
| SCHEMBL7926366 | 0.84 | DPP4 (0.57) | GRM2GRM3GRM6DPP4EPHX2 | |
| SCHEMBL2640274 | 0.83 | EPHX2 (0.47) | GRM2GRM3DPP4EPHX2CTSL | |
| SCHEMBL15306513 | 0.83 | ADAM17 (0.45) | DPP4EPHX2ALDH1A1OPRM1OPRL1 | |
| SCHEMBL297404 | 0.83 | ADAM17 (0.45) | DPP4EPHX2ALDH1A1OPRM1OPRL1 | |
| SCHEMBL31471348 | 0.82 | EPHX2 (0.46) | GRM2GRM3DPP4EPHX2CTSL | |
| SCHEMBL2787488 | 0.81 | GRM2 (0.45) | GRM2GRM3DPP4EPHX2CTSL | |
| SCHEMBL19385743 | 0.81 | OPRM1 (0.46) | GRM2GRM3DPP4EPHX2CTSL | |
| SCHEMBL9960560 | 0.81 | EPHX2 (0.45) | GRM2GRM3DPP4EPHX2CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3354639-B1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2024-02-21 | — | — | EP | disclosed |
| EP-3530648-B1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2023-11-08 | — | — | EP | disclosed |
| US-20220409593-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS | 2022-12-29 | — | — | US | disclosed |
| US-20220409593-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS | 2022-12-29 | — | — | US | disclosed |
| EP-4048677-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | Arkuda Therapeutics (US) | 2022-08-31 | — | — | EP | disclosed |
| US-20210386873-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2021-12-16 | — | — | US | disclosed |
| US-11083804-B2 | Precursor compound of radioactive halogen-labeled organic compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2021-08-10 | — | — | US | disclosed |
| WO-2021081272-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2021-04-29 | — | — | WO | disclosed |
| US-10953112-B2 | Precursor compound of radioactive halogen-labeled organic compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2021-03-23 | — | — | US | disclosed |
| US-20200282082-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2020-09-10 | — | — | US | disclosed |
| EP-1978015-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2008-10-08 | — | — | EP | disclosed |
| EP-1893246-A2 | STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGS FOR TUMOR IMAGING | Emory University (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1889834-A1 | NOVEL ORGANIC COMPOUND AND METHOD FOR PRODUCING RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND USING THE SAME | Nihon Medi-Physics Co., Ltd. (JP) | 2008-02-20 | — | — | EP | disclosed |
| WO-2007001958-A2 | STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGS FOR TUMOR IMAGING | EMORY UNIVERSITY (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20060292073-A1 | Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging | EMORY UNIVERSITY (US) | 2006-12-28 | — | — | US | disclosed |
| EP-0862464-A4 | AMINO ACID ANALOGS FOR TUMOR IMAGING | UNIV EMORY (US) | 2001-07-25 | — | — | EP | disclosed |
| US-5817776-A | TECHNETIUM 99 COMPLEXES, SINGLE PHOTON EMISSION TOMOGRAPHY | EMORY UNIVERSITY (US) | 1998-10-06 | — | — | US | disclosed |
| US-5808146-A | Amino acid analogs for tumor imaging | EMORY UNIVERSITY (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0862464-A1 | AMINO ACID ANALOGS FOR TUMOR IMAGING | EMORY UNIVERSITY (US) | 1998-09-09 | — | — | EP | disclosed |
| WO-1997017092-A1 | AMINO ACID ANALOGS FOR TUMOR IMAGING | EMORY UNIVERSITY (US) | 1997-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060292073-A1 | Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging | PAICS, BCAT1, SLC1A5 | GRM2 1640/4885GRM3 669/4885GRM6 1999/4885 |
| US-11083804-B2 | Precursor compound of radioactive halogen-labeled organic compound | BCAT2, SLCO2B1, ORC3 | GRM2 1092/4885GRM3 2855/4885GRM6 2091/4885 |
| US-20210386873-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | BCAT2, SLCO2B1, ORC3 | GRM2 1092/4885GRM3 2855/4885GRM6 2091/4885 |
| US-20200282082-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | BCAT2, SLCO2B1, ORC3 | GRM2 1092/4885GRM3 2855/4885GRM6 2091/4885 |
| US-10953112-B2 | Precursor compound of radioactive halogen-labeled organic compound | BCAT2, SLCO2B1, ORC3 | GRM2 1092/4885GRM3 2855/4885GRM6 2091/4885 |
| US-20220409593-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | GRN, PSEN1, PSEN2 | GRM2 141/4885GRM3 394/4885GRM6 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.